Based on our observations, a physician should be alarmed if the COVID-19 positive cancer patient presenting to the ED has a history of CHF, received chemotherapy within 1 month, is tachypneic (with respiratory rate above 22), or if his initial lab workup showed an elevated C-Reactive protein and/or procalcitonin values. This evidence concerns the gene CRP and congestive heart failure.